Viscoelastic hemostatic assay (VHAs) are whole blood point-of-care tests that have become
an essential method for assaying hemostatic competence in liver transplantation, cardiac …

Objectives D-dimer elevations, suggesting a pro-thrombotic state and coagulopathy, predict
adverse outcomes in coronavirus disease 2019 (COVID-19). However, the clinical …

Infection by SARS-CoV-2 is associated with a high risk of thrombosis. The laboratory
documentation of hypercoagulability and impaired fibrinolysis remains a challenge. Our aim …

Background Several studies have evaluated the possible association between whole blood
viscoelastic testing (VET) parameters in patients hospitalized for acute Coronavirus disease …

Patients admitted to the intensive care unit (ICU) with coronavirus disease 2019 (COVID-19),
the infectious pathology caused by severe acute respiratory syndrome coronavirus 2, have a …

Background Among the many interesting aspects of clinical care during the SARS-CoV-2
pandemic, vascular access still deserves some attention. Peripherally inserted central …

Thrombosis has been associated with severity and mortality in COVID-19. SARS-CoV-2
infects the host via its spike protein. However, direct effects of spike proteins from SARS-CoV …

Standard biomarkers have been widely used for COVID-19 diagnosis and prognosis. We
hypothesize that thrombogenicity metrics measured by thromboelastography will provide …

Os mecanismos de disfunção da coagulação na COVID-19 são complexos, contudo,
algumas teorias fisiopatológicas já foram postuladas. Esta revisão sistemática objetiva …

Hypercoagulability is a hallmark of COVID-19 and is accompanied by microvascular
thrombosis, mainly in small pulmonary and renal vessels, and an elevated risk of venous …